Switch to:

Keros Therapeutics PB Ratio

: 9.92 (As of Today)
View and export this data going back to 2020. Start your Free Trial

As of today (2021-01-21), Keros Therapeutics's share price is $64.290000. Keros Therapeutics's Book Value per Share for the quarter that ended in Sep. 2020 was $6.48. Hence, Keros Therapeutics's P/B Ratio of today is 9.92.

NAS:KROS' s PB Ratio Range Over the Past 10 Years
Min: 3.37   Med: 7.01   Max: 12.49
Current: 9.94


During the past 2 years, Keros Therapeutics's highest P/B Ratio was 12.49. The lowest was 3.37. And the median was 7.01.

NAS:KROS's PB Ratio is ranked lower than
76% of the 1159 Companies
in the Biotechnology industry.

( Industry Median: 5.00 vs. NAS:KROS: 9.94 )

Back to Basics: P/B Ratio

Keros Therapeutics PB Ratio Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Keros Therapeutics Annual Data
Dec18 Dec19
PB Ratio 0.00 0.00

Keros Therapeutics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
PB Ratio Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 4.68 5.95

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

Keros Therapeutics PB Ratio Distribution

* The bar in red indicates where Keros Therapeutics's PB Ratio falls into.

Keros Therapeutics PB Ratio Calculation

Keros Therapeutics's P/B ratio for today is calculated as follows:

P/B Ratio=Share Price/Book Value per Share (Q: Sep. 2020)

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and Price-to-Book Ratio is that book value other than intangibles are used in the calculation.

Keros Therapeutics  (NAS:KROS) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PS Ratio or Price-to-Free-Cash-Flow, the Price-to-Book Ratio measures the valuation of the stock relative to the underlying asset of the company.

The Price-to-Book Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Keros Therapeutics PB Ratio Related Terms

Keros Therapeutics PB Ratio Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)